LivaNova PLC (NASDAQ:LIVN) Receives $59.29 Average PT from Brokerages

Shares of LivaNova PLC (NASDAQ:LIVN - Get Free Report) have earned a consensus rating of "Buy" from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $59.29.

A number of equities research analysts have weighed in on LIVN shares. Needham & Company LLC reiterated a "buy" rating and set a $64.00 price target on shares of LivaNova in a research report on Tuesday, May 13th. Wolfe Research raised LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 target price on the stock in a research report on Tuesday, May 20th. Stifel Nicolaus lowered their price target on LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a research report on Wednesday, February 26th. Wall Street Zen downgraded LivaNova from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 8th. Finally, The Goldman Sachs Group dropped their target price on LivaNova from $64.00 to $55.00 and set a "buy" rating for the company in a research report on Monday, March 3rd.

Institutional Investors Weigh In On LivaNova

A number of hedge funds have recently bought and sold shares of LIVN. UMB Bank n.a. lifted its holdings in LivaNova by 340.5% during the 1st quarter. UMB Bank n.a. now owns 837 shares of the company's stock worth $33,000 after buying an additional 647 shares during the last quarter. CWM LLC boosted its stake in shares of LivaNova by 52.3% during the first quarter. CWM LLC now owns 871 shares of the company's stock worth $34,000 after buying an additional 299 shares during the period. Caitong International Asset Management Co. Ltd grew its stake in shares of LivaNova by 415.4% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,469 shares of the company's stock valued at $58,000 after purchasing an additional 1,184 shares during the last quarter. Russell Investments Group Ltd. grew its position in LivaNova by 17.1% in the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock valued at $70,000 after buying an additional 219 shares during the last quarter. Finally, Sterling Capital Management LLC boosted its holdings in shares of LivaNova by 800.6% in the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company's stock valued at $75,000 after acquiring an additional 1,441 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

LivaNova Trading Up 1.0%

LIVN stock traded up $0.46 during trading on Friday, reaching $46.03. 420,310 shares of the stock were exchanged, compared to its average volume of 642,150. LivaNova has a 1 year low of $32.48 and a 1 year high of $57.35. The firm has a market capitalization of $2.51 billion, a price-to-earnings ratio of -11.25 and a beta of 0.90. The business has a 50 day moving average price of $41.83 and a 200-day moving average price of $43.54. The company has a current ratio of 1.58, a quick ratio of 1.37 and a debt-to-equity ratio of 0.53.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.